Laser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia.
Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients.
Zhu said laser scleral microporation preserves patients’ distance visual acuity while restoring their dynamic range of focus.
“I think it’s critical because we’re treating the underlying issue,” Zhu said. “The fact that this can be done bilaterally, can be titrated to each patient and their presbyopia needs, and may even be repeatable in the future, I think it’s going to a game changer for refractive surgery.”
Explore More Articles
Dr. Robert Ang in CRST
What other future treatments have promise? Laser scleral microporation is under investigation as a laser treatment for patients with emmetropic presbyopia. Four quadrants of the sclera are treated with an Er:YAG laser to uncrosslink the sclera and rejuvenate the accommodative mechanism (see video demonstration below). Treatment does not appear to affect the visual axis or …
read moreTHE ZOOMING EYE LENS: Effects of Age on Dynamic Range of Focus
DYNAMIC RANGE OF FOCUS (DRoF), or the total range of clear vision in a natural system, is an important biomechanical function of the accommodative apparatus responsible for adjusting the crystalline lens from both far to near (accommodation) and near to far (disaccommodation). DRoF is defined by true accommodation, pseudoaccommodation, and pupillary diaphragmatic changes, which work together …
read moreInsights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast. Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include: 🔹Alex Lopez, …
read more